# Mortality Reduction After Oral Azithromycin: Morbidity Study

> **NCT02048007** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 72000 (actual)

## Conditions studied

- Childhood Mortality

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02048007
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2020-08-27
- **Final completion:** 2020-08-27
- **Target enrollment:** 72000 (ACTUAL)
- **Last updated:** 2021-03-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02048007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02048007, "Mortality Reduction After Oral Azithromycin: Morbidity Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02048007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*